- Rapid digitalization for atrial fibrillation/flutter:
- PO 0.75-1.5mg in divided doses to be given over 24 hours
- Atrial fibrillation/flutter maintenance:
- PO 125-250 mcg daily
- Dose adjusted according to renal function and loading dose
- Heart failure (patients in sinus rhythm):
- Adult: PO 62.5-125 mcg OD
- Children <10 years: 5-10mcg/kg/dose BD
- Emergency loading dose, for atrial fibrillation/flutter:
- IV 0.5-1mg slowly
Tablet:
- 0.25mg
- 0.125mg
- 0.0625mg
Suspension:
- 0.05mg/mL
Injection:
- 0.5mg/2mL
- IV administration administered slowly over a minimum of 5 minutes
- IV digitalization rarely required in chronic heart failure; should only be used in hospitalization under close supervision.
- Mild symptoms, slow digitalization preferred.
Cardiac glycoside
It inhibits NA-K ATPase causing increased intracellular calcium in the myocardium and conduction system causing a subsequent increase in renal perfusion, decreased heart rate and decreased AV node conduction velocity.
- Dizziness
- Mental disturbances
- Diarrhea
- Anorexia
- Bradycardia
- Palpitations
- Ventricular ectopy
- Tachycardia
- Apathy
- Gynecomastia
- Visual disturbances
- Maculopapular rash
- Hypersensitivity to ingredients
- Ventricular fibrillation
- Myocarditis
- Acute MI
- AV block
- Sinus node disease
- NSAIDs
- Amiodarone
- Quinidine
- Chloroquine
- Verapamil
- Diltiazem
- Nicardipine
- Captopril
- Aminoglycosides
- Anticholinergics
- Erythromycin
- Rifampicin
- Antiepileptics
- Barbiturates
Drug Status
Availability | Prescription only |
Pregnancy | Category A |
Breastfeeding | Can be used |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Digitalis | 0.25mg | Tablet | 100’s | Pharma Life Science | Pharma Life Science |
Digomet | 0.125mg | Tablet | 100’s | Metro Pharma | Metro Pharma |
Lanoxin | 0.5mg/2mL | Injection | 5’s | GSK Ltd | GSK Ltd |
Lanoxin | 0.25mg | Tablet | 500’s | GSK Ltd | GSK Ltd |
Lanoxin Elixir | 0.05mg/mL | Suspension | 60mL | GSK Ltd | GSK Ltd |